By Jay Holt, BS in Nutrition (University of Florida)
If you just heard the word “Barrett’s” and went straight to a search bar, take a breath. I’ve lived with acid reflux for 19 years and with Barrett’s esophagus myself, and I want to walk you through what the research actually says about Barrett’s esophagus cancer risk, in plain language.
When I first heard the words “Barrett’s esophagus,” after 19 years of living with acid reflux, I did what almost everyone does. I went home and started searching online, and the more I read, the more scared I got. If that’s where you are right now, I want you to know that feeling is normal, and you’re not alone in it.
Quick note: This article is for education only. I’m a nutrition graduate and a fellow patient, not your gastroenterologist. Your own GI knows your biopsy results and history, so use this to have a better conversation with them, not to replace it.
What Is Barrett’s Esophagus?
Your esophagus is normally lined with flat, tough cells. After years of acid reflux, some of that lining can change into a different type of cell that looks more like the lining of the intestine.
That change is Barrett’s esophagus, your body’s attempt to protect itself from repeated acid.
The American College of Gastroenterology (ACG) describes Barrett’s as the only known precursor to esophageal adenocarcinoma, a type of esophageal cancer. That sentence sounds scary. But “precursor” means a possible starting point, not a destination.
Will Barrett’s Turn Into Cancer? For Most People, No
Here’s the part I wish someone had told me on day one: most people with Barrett’s esophagus never develop cancer.
According to the ACG’s 2022 Barrett’s esophagus guideline (Shaheen and colleagues, American Journal of Gastroenterology), the yearly rate of progression to cancer in non-dysplastic Barrett’s is estimated at roughly 0.05% to 0.2% per year.
Put another way, that’s somewhere between 1 in 2,000 and 1 in 500 people per year at the higher end. The ACG authors themselves call these annual risks low.
Risk does go up when dysplasia is present, which is why the grade on your pathology report matters so much. Let’s break those grades down.
Seeing the actual numbers in writing helped me more than anything I read in those first anxious searches. Fear fills in the blanks with worst case scenarios, and real data gave me something solid to stand on. It didn’t make my diagnosis go away, but it shifted my thinking from panic to a plan.
Dysplasia Grades Explained
Dysplasia means the cells look abnormal under the microscope. It’s graded based on how abnormal they look. Here are the four main categories you’ll see on a pathology report, plus what ACG 2022 generally suggests for each.
Non-dysplastic Barrett’s (NDBE)
The Barrett’s cells are there, but they don’t show precancerous changes. This is the most common result and the lowest-risk category.
Typical surveillance per ACG 2022: a scope every 5 years if your Barrett’s segment is shorter than 3 cm, and every 3 years if it’s 3 cm or longer.
Indefinite for dysplasia
This means the pathologist can’t tell for sure. Often inflammation from active reflux makes the cells hard to read.
Typical next step per ACG 2022: confirm the reading with a second pathologist, increase acid-suppressing medicine to twice daily if you aren’t already on a high dose, and repeat the scope within 6 months.
Low-grade dysplasia (LGD)
The cells show early precancerous changes. This grade is tricky, because pathologists often disagree about it. In one study cited by ACG, expert review downgraded 73% of community LGD diagnoses. For the patients whose LGD was confirmed, progression to high-grade dysplasia or cancer was 9.1% per patient-year.
That’s why ACG 2022 advises having LGD confirmed by an expert GI pathologist. Once confirmed, ACG favors endoscopic eradication therapy (treatment to remove the abnormal tissue). Surveillance is a reasonable alternative after a shared decision with your doctor, usually a scope every 6 months for the first year, then yearly.
High-grade dysplasia (HGD)
The cells show advanced precancerous changes. This is not cancer, but it’s the stage where treatment matters most. ACG 2022 recommends endoscopic eradication therapy for HGD.
Why Barrett’s Surveillance Scopes Matter
Nobody looks forward to an endoscopy. But surveillance is how changes get caught while they’re small, flat, and treatable from inside the esophagus.
During a surveillance scope, your doctor uses high-definition imaging and takes biopsies in four directions at regular intervals along the Barrett’s segment. This is called the Seattle protocol, and ACG recommends it because dysplasia often can’t be seen with the eye alone.
As general guidance from ACG 2022:
- Non-dysplastic, under 3 cm: every 5 years
- Non-dysplastic, 3 cm or longer: every 3 years
- Indefinite for dysplasia: repeat within 6 months after optimizing acid medicine
- Confirmed low-grade dysplasia, if choosing surveillance: every 6 months for a year, then yearly
- High-grade dysplasia: treatment is recommended rather than watching
Your own schedule may differ, so treat this as a map, not a prescription.
I won’t pretend I look forward to my surveillance scopes, but I keep up with every one of them and work closely with my GI. The waiting can stir up nerves, so I try to focus on what I can control. For me, each scope is a check-in that gives me information, and information is a lot easier to live with than worry.
Myth: “Biopsies Can Cause Cancer”
I see this one in reflux forums constantly, and I understand the fear. Barrett’s surveillance biopsies are tiny samples of the lining, and they’re the main way dysplasia is found. The National Cancer Institute (NCI) addresses this worry directly in its Common Cancer Myths page, stating that the chance of surgery or a biopsy causing cancer to spread is extremely low, and that doctors follow standard steps to prevent it.
The cell changes in Barrett’s are driven by long-term reflux, not by sampling. Skipping biopsies doesn’t lower your risk. It only means a change could go unnoticed longer.
Treatment Options for Dysplasia
Dysplasia treatments today are usually done through an endoscope, with no incisions. Here are the three main options in the ACG 2022 guideline.
Endoscopic mucosal resection (EMR): The doctor lifts and removes any visible bump or lesion. This also gives the pathologist a larger piece of tissue for a more accurate diagnosis.
Radiofrequency ablation (RFA): Controlled heat is applied to the flat Barrett’s lining so it can be replaced by normal-type cells. ACG notes that RFA has the widest base of supporting evidence among ablation methods.
Cryoablation (cryotherapy): Extreme cold is used to destroy the abnormal tissue. ACG describes it as an option to consider, especially when RFA hasn’t worked well.
These are often combined: EMR for visible spots, then ablation for the rest. After treatment, follow-up scopes continue, because Barrett’s can come back.
Questions to Ask Your GI
I keep a note on my phone before every appointment. Here are questions worth bringing:
- How long is my Barrett’s segment, and what does that mean for my surveillance interval?
- Was dysplasia found, and which grade?
- Has an expert GI pathologist reviewed my biopsies?
- Is my acid control good enough, or should my medication be adjusted?
- When is my next scope, and why that timing?
- If dysplasia is found, which treatments do you offer, and how many have you performed?
- Are there any symptoms that should make me call before my next scope?
Early on, I didn’t always know what to ask, and I left some appointments with more questions than answers. Over time I learned that my GI is a partner, and that coming in prepared makes every visit more useful. That’s why I keep my list on my phone now.
Daily Habits That Support Reflux Control
Habits don’t treat Barrett’s or replace surveillance, but reflux drives the condition, so keeping it in check matters. The ACG’s 2022 GERD guideline (Katz and colleagues) supports several of these habits.
Timing: ACG suggests avoiding meals within 2 to 3 hours of bedtime. I aim for an early, lighter dinner. My Acid Reflux Diet: Practical Foods & Timing Tips guide walks through how I plan my day.
Sleep position: ACG suggests raising the head of your bed for nighttime symptoms. A wedge pillow or bed risers work better than stacking pillows. The guideline also notes that lying on your right side can increase reflux, so many people do better on the left. More on this in Why Acid Reflux Gets Worse at Night.
Weight: ACG gives a strong recommendation for weight loss in people who are overweight, since extra pressure around the belly pushes acid upward. Even modest progress counts.
Triggers: ACG suggests avoiding your personal trigger foods. Common ones include coffee, chocolate, carbonated drinks, spicy foods, citrus, tomatoes, and high-fat meals. Not everyone reacts to all of them. Start with my Barrett’s Esophagus Food List, and if mornings are your sticking point, read Can I Drink Coffee With Barrett’s Esophagus?
ACG also suggests avoiding tobacco if you have GERD symptoms.
Daily habits are what I lean on most. Timing my meals, not eating late, raising the head of my bed, and knowing my personal triggers have all made a real difference for me. My favorite part of the day is a caffeine-free evening tea ritual that helps me wind down after dinner instead of reaching for a late snack. I won’t say it’s always easy, but consistency matters more than perfection.
FAQ: Barrett’s Esophagus Cancer Risk
Will Barrett’s turn into cancer?
For most people, no. ACG 2022 estimates the yearly cancer progression rate in non-dysplastic Barrett’s at roughly 0.05% to 0.2%. Regular surveillance helps catch rare changes early.
What are the dysplasia grades?
The main categories are non-dysplastic, indefinite for dysplasia, low-grade dysplasia, and high-grade dysplasia. Risk rises with each grade, and so does follow-up.
How often do I need a Barrett’s surveillance scope?
ACG 2022 suggests every 5 years for non-dysplastic Barrett’s under 3 cm and every 3 years for 3 cm or longer. Dysplasia calls for closer follow-up or treatment.
Do biopsies cause cancer?
No. The NCI states that the chance of a biopsy causing cancer to spread is extremely low. Biopsies are how dysplasia is detected in the first place.
Can diet alone manage Barrett’s?
Diet and habits help control reflux, the main driver, but they don’t replace medical care or surveillance.
Living Well With Barrett’s
A Barrett’s diagnosis is a reason to pay attention, not a reason to panic. Know your dysplasia grade, keep your surveillance appointments, and build daily habits that keep reflux quiet.
Today I keep up with my scopes, work with my GI, and stick with the daily habits that keep my reflux quiet. I also run a Facebook group of more than 4,600 people living with reflux and Barrett’s, because I never want someone newly diagnosed to feel as alone as I did during those first late-night searches. If you were just diagnosed, take a breath, get informed, and know there’s a whole community of people walking this road with you.
If you want a simple place to start, grab my free Acid Reflux Food Guide (direct link: https://bit.ly/4cfsgtx). It’s the same food-and-timing framework I use myself.
And if you’re looking for a calming evening ritual, Barrett’s Tea is a caffeine-free herbal blend I created for exactly that moment after dinner. It’s a beverage, not medicine, and it doesn’t treat Barrett’s esophagus or reflux. One important caveat: it contains licorice root. The NIH’s National Center for Complementary and Integrative Health (NCCIH) notes that licorice can cause serious side effects in some people, especially those with high blood pressure or heart or kidney conditions, that it can interact with medications such as corticosteroids, and that large amounts during pregnancy are unsafe. If any of that applies to you, check with your doctor or pharmacist first.
Here’s to fewer flare-ups and more peaceful nights.
Jay
One Response